Jane Street Group, LLC C4 Therapeutics, Inc. Transaction History

Jane Street Group, LLC

$481 Billion
Q2 2025

A detailed history of Jane Street Group, LLC transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 492,612 shares of CCCC stock, worth $1.33 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

492,612

Previous 12,577 3816.77%

Holding current value

$1.33 Million

Previous $20,000 3420.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$1.1 - $1.74 $528,038 - $835,260	480,035 Added 3816.77%	492,612 $704,000
Q1 2025 May 14, 2025	SELL	$1.6 - $4.09 $224,315 - $573,405	-140,197 Reduced 91.77%	12,577 $20,000
Q4 2024 Feb 14, 2025	BUY	$3.6 - $7.0 $299,962 - $583,261	83,323 Added 119.97%	152,774 $549,000
Q3 2024 Nov 14, 2024	SELL	$4.43 - $7.38 $276,498 - $460,622	-62,415 Reduced 47.33%	69,451 $395,000
Q2 2024 Aug 14, 2024	BUY	$4.05 - $8.1 $314,895 - $629,791	77,752 Added 143.68%	131,866 $609,000
Q1 2024 May 15, 2024	SELL	$5.3 - $11.0 $766,152 - $1.59 Million	-144,557 Reduced 72.76%	54,114 $442,000
Q4 2023 Feb 14, 2024	BUY	$1.18 - $6.03 $234,431 - $1.2 Million	198,671 New	198,671 $1.12 Million
Q2 2023 Aug 14, 2023	SELL	$2.75 - $3.77 $5,984 - $8,203	-2,176 Reduced 2.16%	98,565 $271,000
Q1 2023 May 15, 2023	BUY	$3.1 - $9.02 $312,297 - $908,683	100,741 New	100,741 $316,000
Q2 2022 Aug 16, 2022	SELL	$5.06 - $26.46 $102,368 - $535,312	-20,231 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$19.99 - $33.23 $404,417 - $672,276	20,231 New	20,231 $491,000
Q2 2021 Aug 16, 2021	SELL	$30.39 - $42.18 $173,192 - $240,383	-5,699 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$31.96 - $46.5 $182,140 - $265,003	5,699 New	5,699 $211,000

Others Institutions Holding CCCC

# of Institutions

105

Shares Held

57.2M

Call Options Held

15.2K

Put Options Held

View Full List

About C4 Therapeutics, Inc.

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $133M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

More about CCCC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC C4 Therapeutics, Inc. Transaction History